SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72

NIH RePORTER · NIH · N01 · $182,902 · view on reporter.nih.gov ↗

Abstract

The scope of this contract is for formulation development of a solid oral dosage form as tablets, validation of analytical methods on drug products, manufacture of pilot batches, GMP drug product for a phase I clinical trial, and long term stability study under ICH guideline.

Key facts

NIH application ID: 10953952
Project number: 271201700020I-0-759502300001-1
Recipient: IRISYS, INC.
Principal Investigator: ROBERT GIANNINI
Activity code: N01
Funding institute: NIH
Fiscal year: 2023
Award amount: $182,902
Award type: —
Project period: 2023-09-29 → 2028-03-28